{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:36:52Z","timestamp":1792636612354,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T00:00:00Z","timestamp":1505865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T00:00:00Z","timestamp":1505865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Complications of surgical mesh procedures have led to legal cases against manufacturers worldwide and to national inquiries about their safety. The aim of this study was to investigate the rate of adverse events of these procedures for stress urinary incontinence in England over 8 years. This was a retrospective cohort study of first-time tension-free vaginal tape (TVT), trans-obturator tape (TOT) or suprapubic sling (SS) surgical mesh procedures between April 2007 and March 2015. Cases were identified from the Hospital Episode Statistics database. Outcomes included number and type of procedures, including those potentially confounded by concomitant procedures, and frequency, nature and timing of complications. 92,246 first-time surgical mesh procedures (56,648 TVT, 34,704 TOT, 834 SS and 60 combinations) were identified, including 68,002 unconfounded procedures. Peri-procedural and 30-day complication rates in the unconfounded cohort were 2.4 [2.3\u20132.5]% and 1.7 [1.6\u20131.8]% respectively; 5.9 [5.7\u20136.1]% were readmitted at least once within 5 years for further mesh intervention or symptoms of complications, the highest risk being within the first 2 years. Complication rates were higher in the potentially confounded cohort. The complication rate within 5 years of the mesh procedure was 9.8 [9.6:10.0]% This evidence can inform future decision-making on this procedure.<\/jats:p>","DOI":"10.1038\/s41598-017-11821-w","type":"journal-article","created":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T11:06:37Z","timestamp":1505387197000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":138,"title":["Complications following vaginal mesh procedures for stress urinary incontinence: an 8 year study of 92,246 women"],"prefix":"10.1038","volume":"7","author":[{"given":"Kim","family":"Keltie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohier","family":"Elneil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwani","family":"Monga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9553-7278","authenticated-orcid":false,"given":"Andrew J.","family":"Sims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,20]]},"reference":[{"key":"11821_CR1","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/1471-0528.13338","volume":"123","author":"W Gibson","year":"2016","unstructured":"Gibson, W. & Wagg, A. Are older women more likely to receive surgical treatment for stress urinary incontinence since the introduction of the mid-urethral sling? An examination of Hospital Episode Statistics data. B.J.O.G. \n                           123, 1386\u20131392 (2016).","journal-title":"B.J.O.G."},{"key":"11821_CR2","unstructured":"Medicines and Healthcare Products Regulatory Agency, MHRA. A summary of the evidence on the benefits and risks of vaginal mesh implants. https:\/\/www.gov.uk\/government\/publications\/vaginal-mesh-implants-summary-of-benefits-and-risks (2014)."},{"key":"11821_CR3","doi-asserted-by":"publisher","unstructured":"Glazener, C.M.A What is the role of mid-urethral slings in the management of stress incontinence in women? [editorial]. Cochrane Database Syst. Rev. 7, https:\/\/doi.org\/10.1002\/14651858.ED000101 (2015).","DOI":"10.1002\/14651858.ED000101"},{"key":"11821_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i3045","volume":"353","author":"O Dyer","year":"2016","unstructured":"Dyer, O. Johnson and Johnson faces lawsuit over vaginal mesh devices. B.M.J. \n                           353, i3045 (2016).","journal-title":"B.M.J."},{"key":"11821_CR5","unstructured":"U.S. Food and Drug Administration, FDA. U.S. Food and Drug Administration Executive Summary: Reclassification of Urogynecologic Surgical Mesh Instrumentation. http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/MedicalDevices\/MedicalDevicesAdvisoryCommittee\/Gastroenterology-UrologyDevicesPanel\/UCM487224.pdf (2016)."},{"key":"11821_CR6","unstructured":"Hansard record. http:\/\/www.publications.parliament.uk\/pa\/cm201314\/cmhansrd\/cm131202\/text\/131202w0002.htm (2014)."},{"key":"11821_CR7","unstructured":"British Society of Urogynaecology, BSUG. http:\/\/bsug.org.uk\/news-details\/bsug-audit-database\u2013hqip\/43\/12\/0 (2014)."},{"key":"11821_CR8","unstructured":"Scottish Mesh Survivors. http:\/\/www.scottishmeshsurvivors.com\/ (2015)."},{"key":"11821_CR9","unstructured":"Scottish Parliament. Scottish Mesh Survivors. http:\/\/www.scottish.parliament.uk\/GettingInvolved\/Petitions\/scottishmeshsurvivors (2014)."},{"key":"11821_CR10","unstructured":"The Scottish Independent Review of the Use, Safety and Efficacy of Transvaginal Mesh Implants in the Treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse in Women. http:\/\/www.gov.scot\/Publications\/2015\/10\/8485\/downloads (2015)."},{"key":"11821_CR11","first-page":"227","volume":"7","author":"CP Moldovan","year":"2015","unstructured":"Moldovan, C. P., Marinone, M. E. & Staack, A. Transvaginal retropubic sling systems: efficacy and patient acceptability. Int. J. Womens Health \n                           7, 227\u2013237 (2015).","journal-title":"Int. J. Womens Health"},{"key":"11821_CR12","doi-asserted-by":"crossref","unstructured":"Nambiar, A., Cody, J. D., Jeffery, S. T. Single-incision sling operations for urinary incontinence in women. Cochrane Database Syst. Rev. 6 (2014).","DOI":"10.1002\/14651858.CD008709.pub2"},{"key":"11821_CR13","unstructured":"U.S. Food and Drug Administration, FDA. Urogynecologic Surgical Mesh: Update on the Safety and Effectiveness of Transvaginal Placement for Pelvic Organ Prolapse. http:\/\/www.fda.gov\/downloads\/MedicalDevices\/Safety\/AlertsandNotices\/UCM262760.pdf (2011)."},{"key":"11821_CR14","unstructured":"NHS England. Mesh Working Group \u2013 Interim Report. https:\/\/www.england.nhs.uk\/ourwork\/qual-clin-lead\/mesh\/ (2015)."},{"key":"11821_CR15","doi-asserted-by":"crossref","unstructured":"Ford, A. A., Rogerson, L., Cody, J. D., Ogah, J. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst. Rev. 7 (2015).","DOI":"10.1002\/14651858.CD006375.pub3"},{"key":"11821_CR16","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.eururo.2010.04.022","volume":"58","author":"G Novara","year":"2010","unstructured":"Novara, G. et al. Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment of female stress urinary incontinence. Eur. Urol. \n                           58, 218\u2013238 (2010).","journal-title":"Eur. Urol."},{"key":"11821_CR17","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1471-0528.2007.01268.x","volume":"114","author":"PM Latthe","year":"2007","unstructured":"Latthe, P. M., Foon, R. & Toozs-Hobson, P. Transobturator and retropubic tape procedures in stress urinary incontinence: a systematic review and meta-analysis of effectiveness and complications. B.J.O.G. \n                           114, 522\u2013531 (2007).","journal-title":"B.J.O.G."},{"key":"11821_CR18","unstructured":"NHS Digital. Hospital Episode Statistics, HES. http:\/\/content.digital.nhs.uk\/hes (2016)."},{"key":"11821_CR19","unstructured":"NHS Digital. Hospital Admitted Patient Care Activity: 2015\u201316. http:\/\/content.digital.nhs.uk\/catalogue\/PUB22378\/hosp-epis-stat-admi-summ-rep-2015-16-rep.pdf (2016)."},{"key":"11821_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h2685","volume":"350","author":"B Chughtai","year":"2015","unstructured":"Chughtai, B., Mao, J., Buck, J., Kaplan, S. & Sedrakyan, A. Use and risks of surgical mesh for pelvic organ prolapse surgery in women in New York state: population based cohort study. B.M.J. \n                           350, h2685 (2015).","journal-title":"B.M.J."},{"key":"11821_CR21","unstructured":"The R Foundation. The R Project for Statistical Computing. https:\/\/www.r-project.org\/ (2017)."},{"key":"11821_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i886","volume":"352","author":"B Goldacre","year":"2016","unstructured":"Goldacre, B. All BMJ research papers should share their analytic code. B.M.J. \n                           352, i886 (2016).","journal-title":"B.M.J."},{"key":"11821_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.329.7462.369","volume":"329","author":"P Aylin","year":"2004","unstructured":"Aylin, P., Tanna, S., Bottle, A. & Jarman, B. Dr Foster\u2019s case notes: How often are adverse events reported in English hospital statistics? B.M.J. \n                           329, 369 (2004).","journal-title":"B.M.J."},{"issue":"2","key":"11821_CR24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/sj.bjc.6601118","volume":"89","author":"TG Clark","year":"2003","unstructured":"Clark, T. G., Bradburn, M. J., Love, S. B. & Altman, D. G. Survival Analysis Part 1: Basic concepts and first analyses. Br. J. Cancer \n                           89(2), 232\u2013238 (2003).","journal-title":"Br. J. Cancer"},{"key":"11821_CR25","unstructured":"Hess, K., Gentleman, R. muhaz: Hazard Function Estimation in Survival Analysis. https:\/\/cran.r-project.org\/web\/packages\/muhaz\/index.html R package version 1.2.5 (2010)."},{"issue":"12","key":"11821_CR26","first-page":"1167","volume":"150","author":"B Welk","year":"2015","unstructured":"Welk, B., Al-Hothi, H. & Winick-Ng, J. Removal or revision of vaginal mesh used for the treatment of stress urinary incontinence. J.A.M.A. Surgery \n                           150(12), 1167\u20131175 (2015).","journal-title":"J.A.M.A. Surgery"},{"key":"11821_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0140-6736(06)67925-7","volume":"367","author":"P Norton","year":"2006","unstructured":"Norton, P. & Brubaker, L. Urinary incontinence in women. Lancet \n                           367, 57\u201367 (2006).","journal-title":"Lancet"},{"issue":"1","key":"11821_CR28","doi-asserted-by":"publisher","first-page":"73.e1","DOI":"10.1016\/j.ajog.2012.10.006","volume":"208","author":"M Jonsson Funk","year":"2013","unstructured":"Jonsson Funk, M., Siddiqui, N. Y., Pate, V., Amundsen, C. L. & Wu, J. M. Sling revision\/removal for mesh erosion and urinary retention: long-term risk and predictors. Am. J. Obstet. Gynecol. \n                           208(1), 73.e1\u20137 (2013).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"11821_CR29","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1097\/01.AOG.0000146639.62563.e5","volume":"104","author":"CG Nilsson","year":"2004","unstructured":"Nilsson, C. G., Falconer, C. & Rezapour, M. Seven-Year Follow-up of the Tension-Free Vaginal Tape Procedure for Treatment of Urinary Incontinence. Obstet. Gynecol. \n                           104, 1259\u20131262 (2004).","journal-title":"Obstet. Gynecol."},{"issue":"10069","key":"11821_CR30","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(16)32572-7","volume":"389","author":"JR Morling","year":"2017","unstructured":"Morling, J. R. et al. Adverse events after first, single, mesh and non-mesh surgical procedures for stress urinary incontinence and pelvic organ prolapse in Scotland, 1997\u20132016: a population-based cohort study. Lancet \n                           389(10069), 629\u2013640 (2017).","journal-title":"Lancet"},{"issue":"1","key":"11821_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-126","volume":"14","author":"K Keltie","year":"2014","unstructured":"Keltie, K. et al. Identifying complications of interventional procedures from UK routine healthcare databases: a systematic search for methods using clinical codes. B.M.C. Med. Res.Methodol. \n                           14(1), 126 (2014).","journal-title":"B.M.C. Med. Res.Methodol."},{"issue":"2","key":"11821_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/tog.12004","volume":"15","author":"P Moran","year":"2013","unstructured":"Moran, P., Foon, R. & Assassa, P. The BSUG national database: concept, design, implementation and beyond. The Obstetrician and Gynaecologist \n                           15(2), 120\u2013127 (2013).","journal-title":"The Obstetrician and Gynaecologist"},{"key":"11821_CR33","unstructured":"World Health Organisation, WHO. Classification of Diseases. http:\/\/www.who.int\/classifications\/icd\/revision\/en\/ (2016)."},{"key":"11821_CR34","unstructured":"The Audit Commission. Right data, right payment: Annual report on the Payment by Results data assurance programme 2011\/12. https:\/\/www.hsj.co.uk\/Journals\/2012\/08\/31\/l\/g\/b\/Right-data-right-payment-FINAL.pdf (2012)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11821-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11821-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11821-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T06:07:43Z","timestamp":1671775663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11821-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,20]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["11821"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-11821-w","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.731253458.793540880","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,20]]},"assertion":[{"value":"2 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.M. declares personal fees from Pfizer, personal fees from Astellas, personal fees from SEP Pharma, outside the submitted work. All remaining authors (K.K., S.E., H.P., J.P., B.C., A.J.S.) declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12015"}}